跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,530 条关于
“EML4-ALK”
全部
5,530
临床试验
4,186
药物
498
机构
76
资讯
770
8年前
Genetic Variants and Their Impact on Clinical Responses to Treatments
去年
Genprex and University of Michigan Partner to Study Reqorsa® Gene Therapy in ALK+ Lung Cancer
11个月前
Genprex's Reqorsa Gene Therapy Shows 79% Tumor Reduction in ALK-Positive Lung Cancer Preclinical Study
去年
Targeted Therapies and Immunotherapy Advances in Non-Small Cell Lung Cancer: A Comprehensive Review
9年前
FDA Approves Fourth ALK Inhibitor for Lung Cancer
去年
CHOP Researchers Propose ALK Inhibitors as New Standard for Hereditary Neuroblastoma
去年
Lorlatinib Shows Impressive 5-Year PFS Results in ALK-Positive Advanced NSCLC
去年
Gilteritinib Shows Promise as ALK Inhibitor in Acute Myeloid Leukemia
6个月前
TRIANA Biomedicines' TRI-611 Receives FDA Fast Track Designation for ALK+ NSCLC Treatment
3年前
Lorlatinib Shows Promise in ALK-Driven Refractory Neuroblastoma with Emerging Resistance Mechanisms Identified
第 1 页,共 77 页
上一页
下一页